Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Tilray, Inc.
  6. News
  7. Summary
    TLRY   US88688T1007

TILRAY, INC.

(TLRY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Tilray : Still Eyes At Least $1 Billion US Revenue Opportunity While Delta Drives Fiscal First-Quarter Miss

10/07/2021 | 12:36pm EST


ę MT Newswires 2021
All news about TILRAY, INC.
12/03Toronto index turns negative as pot producers weigh
RE
12/02Tilray Launches Fast-Acting Medical Cannabis Oral Strips
MT
12/02Manitoba Harvest Introduces Hemp Hearts Health Hack to Thrive During the Holidays
GL
12/02Launch of Tilray's Fast-Acting Oral Strips Highlights Commitment to Medical Cannabis In..
GL
11/25Greenrise Global Brands Welcomes Germany's Legalization of Cannabis for Adults
MT
11/23CANNABIS STOCKS BRIEF : Barclays Initiates Underwhelming Ratings on Canada Cannabis Cos Du..
MT
11/23TILRAY BRIEF : Given Underweight Rating and US$10 Target at Barclays, adds Barclays
MT
11/22TILRAY, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
11/22Tilray Hosts 2021 Annual Meeting of Shareholders
AQ
11/22SOCIAL BUZZ : Wallstreetbets Trend Higher Lead By Tesla, Lucid, Tilray
MT
More news
Analyst Recommendations on TILRAY, INC.
More recommendations
Financials (USD)
Sales 2022 758 M - -
Net income 2022 - - -
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 4 147 M 4 147 M -
Capi. / Sales 2022 5,47x
EV / Sales 2023
Nbr of Employees 2 100
Free-Float 98,6%
Chart TILRAY, INC.
Duration : Period :
Tilray, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TILRAY, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 21
Last Close Price 8,95 $
Average target price 13,92 $
Spread / Average Target 55,6%
EPS Revisions
Managers and Directors
Irwin David Simon Chairman & Chief Executive Officer
Carl A. Merton Chief Financial Officer
Joshua Eades Chief Science Officer
Catherine Jacobson Vice President-Regulatory & Medical Affairs
Lloyd Brathwaite Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
TILRAY, INC.15.50%4 420
JOHNSON & JOHNSON-0.18%413 555
ROCHE HOLDING AG17.62%341 509
PFIZER, INC.44.09%297 706
NOVO NORDISK A/S64.51%243 534
ELI LILLY AND COMPANY47.55%224 726